Literature DB >> 23664199

A prospective study of risk factors for neurological complications in childhood bacterial meningitis.

Sadie Namani1, Zvonko Milenković, Bulëza Koci.   

Abstract

OBJECTIVE: To prospectively analyze the prognostic factors for neurological complications of childhood bacterial meningitis.
METHODS: This prospective study enrolled 77 children from 1 month until 16 years of age, treated for bacterial meningitis during the period of January 1, 2009 through December 31, 2010. 16 relevant predictors were chosen to analyze their association with the incidence of neurological complications. p-values < 0.05 were considered statistically significant.
RESULTS: Of the 77 children treated for bacterial meningitis, 33 patients developed neurological complications (43%), and two children died (2.6%). The etiology of bacterial meningitis cases was proven in 57/77 (74%) cases: 32 meningococci, eight pneumococci, six Gram-negative bacilli, five H. influenzae, five staphylococci, and one S. viridans isolates were found. Factors found to be associated with increased risk of development of neurological complications were age < 12 months, altered mental status, seizures prior to admission, initial therapy with two antibiotics, dexamethasone use, presence of focal neurological deficit on admission and increased proteins in cerebrospinal fluid (CSF) (p < 0.05). Initial pleocytosis > 5,000 cells/mm(3), pleocytosis > 5,000 cells/mm(3) after 48 hours, CSF/blood glucose ratio < 0.20, female gender, previous treatment with antibiotics, community-acquired infection, duration of illness > 48 hours, presence of comorbidity, and primary focus of infection were not associated with increased risk for the development of neurological complications.
CONCLUSION: Age < 12 months and severity of clinical presentation at admission were identified as the strongest predictors of neurological complications and may be of value in selecting patients for more intensive care and treatment.
Copyright © 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664199     DOI: 10.1016/j.jped.2012.10.001

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  6 in total

1.  Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.

Authors:  Bilal Ahmad Rahimi; Niamatullah Ishaq; Ghulam Mohayuddin Mudaser; Walter R Taylor
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

2.  Risk Factors Associated With Prolonged Antibiotic Use in Pediatric Bacterial Meningitis.

Authors:  Cuiyao He; Xiaogang Hu; Tingsong Li; Qing Wu; Jisan Fan; Yan Zhou; Li Jiang; Siqi Hong; Yuanyuan Luo
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

3.  Treatment Outcomes and Associated Factors among Children Hospitalized with Acute Bacterial Meningitis in Eastern Ethiopia: A Cross-Sectional Study.

Authors:  Fuad Adem; Amanuel Tasew; Ammas Siraj; Mesud Mohammed
Journal:  Patient Relat Outcome Meas       Date:  2020-12-23

4.  Nationwide Population-Based Epidemiological Study for Outcomes of Adjunctive Steroid Therapy in Pediatric Patients with Bacterial Meningitis in Taiwan.

Authors:  Dong-Yi Hsieh; Yun-Ru Lai; Chia-Yi Lien; Wen-Neng Chang; Chih-Cheng Huang; Ben-Chung Cheng; Chia-Te Kung; Cheng-Hsien Lu
Journal:  Int J Environ Res Public Health       Date:  2021-06-12       Impact factor: 3.390

Review 5.  Bacterial Meningitis in Children: Neurological Complications, Associated Risk Factors, and Prevention.

Authors:  Abdulwahed Zainel; Hana Mitchell; Manish Sadarangani
Journal:  Microorganisms       Date:  2021-03-05

6.  Risk factors associated with the outcomes of pediatric bacterial meningitis: a systematic review.

Authors:  Daniela Caldas Teixeira; Lilian Martins Oliveira Diniz; Nathalia Sernizon Guimarães; Henrique Morávia de Andrade Santos Moreira; César Caldas Teixeira; Roberta Maia de Castro Romanelli
Journal:  J Pediatr (Rio J)       Date:  2019-08-19       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.